Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.
about
CIViC databaseFrequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical ApproachRapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Prevalence of Abelson murine leukemia viral oncogene homolog-breakpoint cluster region fusions and correlation with peripheral blood parameters in chronic myelogenous leukemia patients in Lorestan Province, Iran.Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.Current trends in molecular diagnostics of chronic myeloid leukemia.Accurate prediction of the age incidence of chronic myeloid leukemia with an improved two-mutation mathematical model.Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone.Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring.Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients.Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell.Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.[Chronic myelogenous leukemia].
P2860
Q27612411-0E359FF8-C6AA-44BA-B18D-CB7E3DC8770FQ33701852-4B514801-7D4A-4635-A0EC-6F6EE6F7A343Q33888064-77F15337-DC40-46A2-9605-C3601BDCE7F5Q37389361-7AA751C3-64C1-4B92-910A-CD5042D911CBQ37412144-DA21B7D5-62D1-49D7-8BD2-BF3A09B54EB8Q38699939-ACCBFEA4-9EEE-4DA1-9EB5-F9F96FFB087AQ38787015-C6CE8733-CE1F-4F30-B1C7-A14665A84C44Q39228166-21791895-ACD5-4488-A2F0-1F1488E0CFACQ40607863-B45CF0A2-6178-45D4-99B7-A941759AC310Q42330162-0E6EAD1D-2FC4-40CC-8CA2-A4B791CF484EQ42665076-A35230D6-EC87-4EEA-84D9-894CBA49565FQ43120262-87F3D429-B113-4F8A-8100-8CC581CB6347Q47132357-651E9362-629C-4C53-8139-62BCA8228CECQ47797877-3486B475-5489-49F1-BA93-1651859C1D31Q48029219-92C81CE9-A6DD-483F-90A7-1346FC5ABC77Q48109003-9FE86466-9675-4A18-B3A4-B6CB95631F7DQ48124486-43507FD0-AC77-4770-9CE3-DFDA0B6BCD7CQ49888044-407CE0F1-3ECE-4B0A-963D-73BC36E665BFQ53098890-F263099F-AEC9-49F4-A276-A4CA19CFFA59Q54167458-79BFAB63-A3A1-4E10-BD21-010B7E4F5056
P2860
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@ast
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@en
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@nl
type
label
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@ast
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@en
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@nl
prefLabel
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@ast
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@en
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Molecular-defined clonal evolu ...... pendent of the BCR-ABL status.
@en
P2093
A Kohlmann
E Eigendorff
E Obstfelder
J Ziermann
N Winkelmann
S Schnittger
P2860
P2888
P304
P3181
P356
10.1038/LEU.2014.272
P577
2014-12-01T00:00:00Z
P5875
P6179
1005714107